Sharda Cropchem Limited — Investor Meet, 06-11-2025: Analysts/Institutional Investor Meet/Con. Call Updates

Sharda Cropchem delivered strong Q2 FY26 results with revenue up 20% to INR 929 Cr and PAT soaring 75% to INR 74 Cr. Half-year (H1) revenue grew 23% to INR 1,914 Cr, with PAT surging 212% to INR 217 Cr. Gross margins expanded to 34.5% (Q2) and 35% (H1), driven by global demand recovery and stabilizing input costs. Management foresees improving agrochemical demand, projecting FY26 EBITDA margins of 15-18%. The company's extensive product registrations (2,994) and ability to pass on US tariffs are notable strengths. Working capital improved, and Sharda remains debt-free with INR 794 Cr in cash. The outlook for H2 is positive due to business seasonality.